Mandate

Vinge advises Schibsted Tillväxtmedier in connection with its divestment of Prisjakt

Schibsted Tillväxtmedier has entered into an agreement for the sale of Prisjakt to eEquity. The consideration is expected to amount to around SEK 500 million. Schibsted has owned Prisjakt for approximately 20 years and the divestment is made as part of Schibsted’s ongoing streamlining of its organisation and portfolio.

The transaction is expected to close in June 2025 and is conditional upon approval from the Swedish Competition Authority.

Vinge’s team consisted mainly of Johan Larsson, Johan Winnerblad and Gustav Wahlberg (M&A), Nicklas Thorgerzon (GDPR), Eva Fredrikson, Christoffer Nordin, Siri Blomberg and Carl Lexenberg (Kommersiella avtal), Alice Göransson (Commercial agreements) as well as Johan Gavelin (IP).

Related

Vinge has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS

Vinge, together with Advokatfirmaet Thommessen, has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS from Å Energi owned Nettpartner AS.
January 19, 2026

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026

Vinge advises Revivo Group on acquisition of Haapanen

Revivo Group, a comprehensive provider of qualified surface treatment services, has acquired Haapanen, a well-established Finnish specialist company.
January 14, 2026